Global Respiratory Diagnostics Market

Global Respiratory Diagnostics Market was valued at USD 10.49 Bn in 2025 and is expected to reach USD 17.18 Bn by 2032, growing at a CAGR of 7.3% during the forecast period.

The Respiratory Diagnostics market report is a comprehensive analysis of the industry, market, and key players. The report has covered the market by demand and supply-side by segments. The Global Respiratory Diagnostics report also provides trends by market segments, Diseases, and investment with a competitive landscape.

To know about the Research Methodology :- Request Free Sample Report

Global Respiratory Diagnostics Market Overview:

Respiratory disease testing includes various tests that are carried out to identify the cause of the disease. Test like Bronchoscopy, Chest Tube Procedure, CT Scan, CT Scan-Guided Lung Biopsy, Endobronchial Ultrasound (EBUS), Exhaled Nitric Oxide Test, Lobectomy, Lung Function Tests, and various others. This test is performed on the lungs and identifies the infected area by bacteria, fungi, or pathogens.

Global Respiratory Diagnostics Market Dynamics:

Rising pollution in the environment is boosting the market of respiratory diagnosis market. People around the globe have inculcated various bad habits that infect lungs and destroy them internally at a low pace and with time it increases the severity of the disease. For example, smoking and drinking habits affect badly the human body. Moreover, in the US 80-90% of deaths are caused due to cigarette smoking and are added as a major risk factor to the lung. Further, 90% of deaths are occurred in low and middle-income countries due to COPD.

Besides, the growing advances in technological investment and in-vitro diagnostic test with the new generation is further boosting the demand of global respiratory diagnostics market in the forecast period of 2022-2029. Additionally, growing awareness in an individual due to the digital market is fueling the market and the low purchasing power of an individual can hamper the growth of the market as the diagnostic test are expensive and middle-class families cannot afford this

Moreover, the installation of diagnostic devices in multispecialty hospitals and private hospitals, healthcare centers, and government initiatives like healthcare programs is further boosting the market of respiratory diagnostics in the forecast period.

Instrument and device are dominating the product and service segment of the Respiratory Diagnostics Market:

The instrument and device segment has gained more attention in the forecast period due to innovation and rapid technological investment in the market. Devices like multi-purpose imaging machines like CT scans and X-Ray, ultrasound imaging, MRI system, nuclear imaging system, and mammography imaging system. CT scans, X-rays have accounted for a major market share in the forecast period of 2023-2029. Due to the clear appearance of infected areas in the lungs and precise diagnosis. Moreover, The X-ray market was valued at 13.22 billion with a CAGR of 4.7% in the year 2022. The instrument and device segment is growing at a rapid pace due to growing industrialization and development in countries is further motivating the market to increase the investment in machinery.

The tuberculosis segment is expected to trend in the diseases segment of the Respiratory Diagnostics Market Demand:

The global tuberculosis segment is dominating the diseased segment of the respiratory diagnostic market due to the high prevalence of diseases in the world population. There are two types of tuberculosis active tuberculosis and latent tuberculosis. In 2022, 1.76 billion people were affected by tuberculosis that is 26% of the total world population. Moreover, Tuberculosis is also leading in terms of infectious diseases and around 1.59 million lives are affected each year globally. Tuberculosis is most common in Africa, the West Pacific, Eastern Europe, further these regions have also accounted for limited resources due to low economic development. The Asia Pacific accounts for 58.1% of the market share in the tuberculosis therapeutics market in 2022.

Hospital and Clinical laboratories are dominating the end-user segment of the Global Respiratory Diagnostics Market:

In 2025, the Instruments and Devices segment accounts for the highest demand in the respiratory diagnostics market. Devices such as spirometers, gas analyzers, and imaging systems are widely used in hospitals and diagnostic laboratories for evaluating lung function and detecting respiratory disorders. These instruments play a critical role in diagnosing conditions like asthma and chronic obstructive pulmonary disease (COPD). Assays and Reagents are also experiencing steady growth due to the increasing use of molecular diagnostic tests for infectious respiratory diseases. Meanwhile, Services and Software are gaining importance as healthcare providers adopt digital platforms and data management tools to improve diagnostic efficiency and streamline patient monitoring.

Based on Test Type, Pulmonary Function Tests represent the most demanded segment in 2025. These tests, including spirometry and lung volume measurement, are widely used to assess lung capacity and airflow obstruction in patients with chronic respiratory diseases. Imaging Tests, such as chest X-rays and CT scans, are also extensively utilized for detecting structural abnormalities and lung infections. Molecular Diagnostic Tests are witnessing rapid growth due to their ability to accurately detect pathogens responsible for respiratory infections. Gas Exchange Tests and Peak Flow Measurement Tests continue to support routine monitoring and early detection of respiratory conditions, particularly in clinical and home-care settings.

Based on Disease, Chronic Obstructive Pulmonary Disease (COPD) represents the largest demand segment in 2025, primarily due to the high global prevalence of smoking, air pollution, and aging populations. Asthma is another major segment, with increasing diagnosis rates and continuous monitoring requirements driving demand for respiratory diagnostic tests. Tuberculosis remains a critical area of focus, especially in developing regions where early and accurate diagnosis is essential for disease control. Lung Cancer diagnostics are also expanding due to the growing adoption of imaging and molecular testing techniques for early detection. Other respiratory diseases contribute to overall market demand through routine screening and monitoring needs.

Regional Insights:

The objective of the report is to present a comprehensive analysis of the Global Respiratory Diagnostics Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding the Global Respiratory Diagnostics Market dynamics, structure by analyzing the market segments and project the Global Respiratory Diagnostics Market size. Clear representation of competitive analysis of key players by Type, price, financial position, Type portfolio, growth strategies, and regional presence in the Global Respiratory Diagnostics Market make the report investor’s guide

Global Respiratory Diagnostics Market Scope: Inquire before buying

Global Respiratory Diagnostics Market, by Region

Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
North America (United States, Canada and Mexico)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Key Players /Competitor Profiles Covered in the Global Respiratory Diagnostics Market Report from a Strategic Perspective.

1. Koninklijke Philips N.V.
2. Medtronic plc
3. Abbott Laboratories
4. F. Hoffmann-La Roche Ltd
5. Thermo Fisher Scientific Inc.
6. Bio-Rad Laboratories Inc.
7. bioMérieux SA
8. NIHON KOHDEN CORPORATION
9. Drägerwerk AG & Co. KGaA
10. ResMed Inc.
11. Masimo Corporation
12. Vyaire Medical Inc.
13. MGC Diagnostics Corporation
14. COSMED srl
15. Geratherm Medical AG
16. Vitalograph Ltd
17. Seegene Inc.
18. QuidelOrtho Corporation
19. Hillrom Holdings Inc.
20. BD
21. SDI Diagnostics Inc.
22. Schiller AG
23. ndd Medical Technologies
24. Smiths Medical
25. Carestream Health